by Eric Christianson | Nov 22, 2020 | Clinical Pharmacy News and New Drug Updates
Working with geriatric patients and providers in primary care, I definitely have to stay up to date with regards to diabetes therapy. There have been a couple of diabetes updates in 2020 that I wanted to make sure you were aware of. The SGLT2 inhibitors is a class of...
by Eric Christianson | May 20, 2020 | Clinical Pharmacy News and New Drug Updates
I stumbled into this article a while ago regarding Nuedexta off-label fraud for behavioral issues involving dementia patients in long term care facilities. It makes me sad and frustrated. I’d like to make a couple of points. Nuedexta Off-Label Evidence in...
by Eric Christianson | Apr 29, 2020 | Clinical Pharmacy News and New Drug Updates
Need a little clarity on COVID-19? I’ve been listening, watching, and paying attention daily. Assessing COVID-19 and its impact has been difficult in my opinion due to the sporadic testing data and the lack of confidence from information coming out from other...
by Eric Christianson | Mar 22, 2020 | Clinical Pharmacy News and New Drug Updates
The world is a buzz with COVID-19 news and rightfully so. I want to cover hydroxychloroquine clinical pearls. This drug has been purported to have activity against coronavirus. Here’s a link to that research article. Uses of Hydroxychloroquine While it is...
by Eric Christianson | Mar 18, 2020 | Clinical Pharmacy News and New Drug Updates
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as...
by Eric Christianson | Jan 19, 2020 | Clinical Pharmacy News and New Drug Updates
FDA Approval The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m seeing used in clinical practice, this is a great thing for overall healthcare and drug costs. Here’s the FDA’s statement. Because of this...
